Bill
Bill > SB1025
OK SB1025
OK SB1025Health care; creating the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025; clarifying authority to take certain actions. Effective date.
summary
Introduced
02/03/2025
02/03/2025
In Committee
02/04/2025
02/04/2025
Crossed Over
Passed
Dead
Introduced Session
2025 Regular Session
Bill Summary
An Act relating to health care; amending 36 O.S. 2021, Sections 6960 and 6962, as last amended by Sections 1 and 2, Chapter 306, O.S.L. 2024 (36 O.S. Supp. 2024, Sections 6960 and 6962), which relate to definitions and pharmacy benefits manager compliance; defining terms; creating pharmacy benefits manager disclosures; creating duties; creating the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025; providing short title; clarifying authority to take certain actions; prohibiting the disclosure of certain information; declaring that certain information not be considered public record; defining terms; providing cost sharing calculation methodology, limitations, and requirements; creating penalties; providing certain exceptions; amending 36 O.S. 2021, Section 6964, which relates to a formulary for prescription drugs; creating agency duties; amending 59 O.S. 2021, Sections 357 and 358, as amended by Sections 4 and 5, Chapter 332, O.S.L. 2024 (59 O.S. Supp. 2024, Sections 357 and 358), which relate to definitions and pharmacy benefits management licensure, procedure, and penalties; modifying definitions; creating duties; creating licensing application requirements; providing for noncodification; providing for codification; and providing an effective date.
AI Summary
This bill introduces the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025, which aims to regulate pharmacy benefits managers (PBMs) and health insurers in Oklahoma by expanding transparency and consumer protections in prescription drug pricing. The bill significantly modifies existing laws by defining new terms, establishing stricter requirements for PBMs and health insurers, and creating new disclosure and pricing standards. Key provisions include mandating that at least 85% of drug rebates be passed through to consumers at the point of sale, which could lower out-of-pocket prescription costs, and imposing new requirements on pharmacy and therapeutics (P&T) committees to ensure more transparent and clinically-driven formulary development. The bill also strengthens licensing requirements for PBMs, requiring more detailed applications and giving the Insurance Department and Attorney General expanded oversight and enforcement powers. Additionally, the legislation protects certain proprietary information as confidential and imposes administrative penalties for violations, with fines ranging from $100 to $10,000 per occurrence. These changes aim to increase transparency, reduce prescription drug costs, and provide more accountability in the pharmacy benefits management industry.
Committee Categories
Business and Industry
Sponsors (2)
Last Action
Senate Business and Insurance REVISED Hearing (09:30:00 3/6/2025 Room 535) (on 03/06/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...